SEC Form D · Amendment · filed October 20, 2016
Oncternal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Cam L. Garner · San Diego, CADirectorDavid J. Winograd · Milwaukee, WIExec · DirectorDavid B. Johnson · San Diego, CADirectorThomas A. Roszak · Northfield, ILExecErin T. Duffy · New Haven, CTExecGarheng P. Kong · New Haven, CTDirectorJames B. Breitmeyer, M.D., Ph.D · San Diego, CAExec · DirectorDavid F. Hale · San Diego, CADirectorSteven Kay · San Francisco, CAExecCalvin E. Webb, Iii · Waxahachie, TXDirectorBrad Fay · Bismarck, NDExecLangdon G. Miller · San Diego, CAExecAllen R. Page · Waxahachie, TXDirectorScott L. Glenn · San Diego, CADirectorCraig Lloyd · Sioux Falls, SDDirectorMichael Krupka · BOSTON, MAExecStan Johnson · Fargo, NDDirectorMichael A. Moceri · Chicago, ILDirectorDenise Woodard · Jersey City, NJDirectorLauren G. Otsuki · San Diego, CAExecJames F. Corum · Waxahachie, TXExecRay Braun · Valley City, NDDirectorLCM Funds Asset Manager LLC · Milwaukee, WIExecBrian B. Lannutti · San Diego, CAExecPaul T. Estrem · New Haven, CTExec · DirectorMark Jorgensen · San Francisco, CADirectorDana B. Mcgowan · San Diego, CAExecGene Smestad · Valley City, NDExecGayle Troberman · New York, NYDirectorCam B. Gallagher · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗